Among patients suffering from Cushing’s syndrome, over 30% will develop diabetes [28], associated with an impaired glucose tolerance and a decrease in insulin sensitivity prior to the clinical stage of the disease, suggesting that some individuals are more likely prone to develop diabetes in response to supraphysiological GC doses. This evidence concerns the gene INS and diabetes mellitus.